Tresiba Alternatives Compared
Tresiba | Humalog | Lantus |
|
---|
Tresiba (insulin degludec) | Humalog (insulin lispro) | Lantus (insulin glargine) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Tresiba contains insulin degludec, an ultra-long-acting insulin that starts to work 60 minutes after administration and keeps working for up to 42 hours. Tresiba is approved for use in adults and... View more |
Prescription only
Humalog is a fast-acting insulin that may be used in conjunction with either intermediate or long-acting insulin for the treatment of diabetes in adults and type 1 diabetes in children over the age... View more |
Prescription only
Lantus is a long-acting insulin that only needs to be injected once a day, subcutaneously. It is available as a prefilled pen (Lantus Solostar) or a 10mL vial. Hypoglycemia is the most common side... View more |
Related suggestions Diabetes, Type 2
Diabetes, Type 1
Popular comparisons
|
|||||||||||||||||||||||
More about Tresiba (insulin degludec) | More about Humalog (insulin lispro) | More about Lantus (insulin glargine) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Tresiba has an average rating of 4.2 out of 10 from a total of 150 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 57% reported a negative effect. |
Humalog has an average rating of 6.9 out of 10 from a total of 20 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 17% reported a negative effect. |
Lantus has an average rating of 6.6 out of 10 from a total of 41 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Tresiba side effects in more detail. |
See also: Humalog side effects in more detail. |
See also: Lantus side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Tresiba prices |
View all Humalog prices |
View all Lantus prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Other insulin lispro brands include: Admelog, Humalog Junior KwikPen, Humalog KwikPen, Lyumjev | Other insulin glargine brands include: Basaglar, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
25 hours |
1 hour |
24 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 383 drugs are known to interact with Tresiba:
|
A total of 385 drugs are known to interact with Humalog:
|
A total of 385 drugs are known to interact with Lantus:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
June 14, 1996 |
April 20, 2000 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.